# A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World Practice

> **NCT04890262** · — · COMPLETED · sponsor: **Takeda** · enrollment: 99 (actual)

## Conditions studied

- Inflammatory Bowel Diseases
- Crohns Disease
- Colitis, Ulcerative

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04890262
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-18
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2024-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04890262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04890262, "A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World Practice". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04890262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*